Heme oxygenase‐1 attenuates the inhibitory effect of bortezomib against the APRIL‐NF‐κB‐CCL3 signaling pathways in multiple myeloma cells: Corelated with bortezomib tolerance in multiple myeloma-Reference-Cited by-同舟云学术

Heme oxygenase‐1 attenuates the inhibitory effect of bortezomib against the APRIL‐NF‐κB‐CCL3 signaling pathways in multiple myeloma cells: Corelated with bortezomib tolerance in multiple myeloma

Published:2018-10-28 Issue:5 Volume:120 Page:6972-6987
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

He Zheng C.¹²³,Li Xin Y.¹²³,Guo Yong L.¹²³,Ma Dan¹²³,Fang Qin⁴,Ren Ling L.⁵,Zhang Zhao Y.¹²³,Wang Weili¹²³,Yu Zheng Y.¹²³,Zhao Peng¹²³,Wang Ji S.¹²³^ORCID

Affiliation:

1. Department of Hematology Affiliated Hospital of Medical University Guiyang China

2. Hematological Institute of Guizhou Province, The Affiliated Hospital of Guizhou Medical University Guiyang China

3. Guizhou Provincial Laboratory of Hematopoietic Stem Cell Transplantation Centre, The Affiliated Hospital of Guizhou Medical University Guiyang China

4. Department of Pharmacy The Affiliated Hospital of Guizhou Medical University Guiyang China

5. Department of Hematology Affiliated Hospital of North Sichuan Medical College Nanchong China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27879

Reference43 articles.

1. Front-line therapies for elderly patients with transplant-ineligible multiple myeloma and high-risk cytogenetics in the era of novel agents